Intensity Therapeutics Inc.

INTS | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.90

-$0.12 (-2.99%)

Sep 22, 2026, 10:47 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	11.92M	2.59M	8.56M	1.31M	4.54M	9.32M
Short-Term Investments	n/a	n/a	6.22M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.3M	1.3M	1.68M	167K	167.74K	181.7K
Receivables	n/a	n/a	n/a	62.3K	51.26K	48.52K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	6K	13.7K	69.28K	46.18K
Total Current Assets	12.71M	3.36M	15.46M	1.45M	4.73M	9.48M
Property-Plant & Equipment	96K	122K	147K	139K	318.13K	490.24K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.39M	1.42M	1.83M	306K	485.86K	671.94K
Total Assets	14.1M	4.78M	17.3M	1.76M	5.22M	10.15M
Account Payables	583K	1.22M	3.05M	603K	172.51K	222.71K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	4.35M	2.02M	n/a
Other Current Liabilities	800K	56K	499K	n/a	n/a	n/a
Total Current Liabilities	2.15M	1.76M	3.96M	6.82M	3.72M	1.35M
Long-Term Debt	79K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	36K	10.04M	10.04M	10.04M
Total Long-Term Liabilities	79K	110K	174K	10.04M	10.18M	10.36M
Total Liabilities	2.23M	1.87M	4.13M	16.86M	13.9M	11.71M
Total Debt	110K	138K	158K	4.49M	2.34M	497.48K
Book Value	11.88M	2.92M	13.16M	-15.1M	-8.68M	-1.56M
Book Value Per Share	0.88	5.25	38.19	-110.69	-63.66	-11.43
Common Stock	n/a	2K	1K	n/a	341	682
Retained Earnings	-78.39M	-66.78M	-50.52M	-38.65M	-31.07M	-23.18M
Comprehensive Income	n/a	n/a	-17.3M	n/a	n/a	n/a
Shareholders Equity	11.88M	2.92M	13.16M	-15.1M	-8.68M	-1.56M
Total Investments	n/a	n/a	6.22M	n/a	n/a	n/a